VAERS Explorer
Back to explore

Report #2891242

Received Mar 31, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
Recovered
Recovered
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK

Symptoms (3)

Injection site discolourationInjection site pruritusMigraine

Symptom narrative

had white spots appear at the injection site with the first shot; injection site was itchy; The vaccines gave me a migraine; Unexpected beneficial therapeutic response; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of injection site discoloration in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (had it from November to February). On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced injection site discoloration (Verbatim: had white spots appear at the injection site with the first shot), injection site itching (Verbatim: injection site was itchy), migraine (Verbatim: The vaccines gave me a migraine) and unexpected beneficial therapeutic response (Verbatim: Unexpected beneficial therapeutic response). The outcome of the injection site discoloration, injection site itching and migraine were resolved and the outcome of the unexpected beneficial therapeutic response was not applicable. It was unknown if the reporter considered the injection site discoloration and injection site itching to be related to Shingles vaccine. The reporter considered the migraine to be related to Shingles vaccine. It was unknown if the company considered the injection site discoloration and injection site itching to be related to Shingles vaccine. The company considered the migraine to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 22-MAR-2026 This case was reported by a patient via interactive digital media. The doctor told she to wait six months before receiving the first Shingles vaccine. Then she had the booster (2nd shot) two months later. Initially, she had white spots appear at the injection site with the first shot, but they went away after a while. The injection site was itchy and that went away too. The vaccines gave her a migraine and that went away. In the end, the vaccines helped her body kick the Shingles. The patient had several flare ups before the vaccines, but everything went away after the vaccines. The vaccines where an absolute must whether to prevent Shingles off the bat or to ensure one never got it again. The vaccines were unpleasant but better than the hellish outbreak and nerve pain that one got with Shingles. The follow-up could not be possible as no contact details were available. The batch number was not provided, and we are unable to contact the reporter.

Medical history

Medical History/Concurrent Conditions: Shingles (had it from November to February)